Jacobs Solutions (J) 47th Annual Raymond James Institutional Investor Conference summary
Event summary combining transcript, slides, and related documents.
47th Annual Raymond James Institutional Investor Conference summary
5 Mar, 2026Business overview and market positioning
Operates in technical advisory, engineering, and program delivery across life sciences, water/environmental, and critical infrastructure verticals.
Strong focus on technology innovation and addressing major global challenges through capital project delivery.
Deep expertise in engineering, with a legacy dating back to the 1940s.
Advanced facilities and AI-driven growth
Data center business, now 3-4% of revenue, is doubling annually, driven by AI and advanced chip requirements.
Engagements have grown from small-scale to large, complex projects with hyperscalers and neocloud providers.
Expertise in power and water supports high-bandwidth memory chip manufacturing and the broader AI ecosystem.
Life sciences and advanced manufacturing
Life sciences generates about $1 billion in service revenue, with growth fueled by AI-driven drug discovery and onshoring.
Focus on tier-one pharma clients, with business growing at high single to low double digits.
Life sciences and advanced manufacturing together make up 25% of revenue, growing at high single digits.
Growth drivers include GLP-1 innovations, Alzheimer's research, and antibody-drug conjugates.
Latest events from Jacobs Solutions
- Record backlog, digital growth, and margin expansion drive strong outlook through 2029.J
Barclays 43rd Annual Industrial Select Conference18 Feb 2026 - Record growth and margin expansion driven by AI, digital, and global delivery initiatives.J
Citi's Global Industrial Tech & Mobility Conference 202617 Feb 2026 - Strong growth, digital innovation, and margin expansion drive robust multi-year financial outlook.J
Investor presentation6 Feb 2026 - Q1 FY2026 delivered strong growth, higher earnings, and raised guidance, with PA Consulting acquisition.J
Q1 20263 Feb 2026 - Targets 6%-8% organic growth, 10%+ FCF margin, and digital-led expansion by FY29.J
Investor Day 20253 Feb 2026 - Board elections, executive pay, and auditor ratification passed with strong support.J
AGM 20263 Feb 2026 - Strong Q3 margins, record backlog, and robust cash flow; CMS spin-off on track for September.J
Q3 20242 Feb 2026 - A $14B revenue, $47B backlog leader targets strong growth, margin expansion, and innovation.J
Amentum CMD 20242 Feb 2026 - Strong FY24 results, record backlog, and robust FY25 outlook post-Amentum separation.J
Q4 202413 Jan 2026